"Were people trading on the predictable good news ann. pre AGM?" - Maybe - some posts on this forum suggested takeover talks at AGM.
"Lenses were clearly off the table. So much for my hope that Ciba could lend a hand with a useful biomaterial." Directors said to expect announcements on lenses within next 6 months
"Oil and gas. Mass production of compound soon in India or China. Compound is more expensive that existing biocides - read low margins - but may be more effective, particularly in dislodging formed biofilms."
If it's more effective and has less handling costs, BOS can justify selling it for more so margins may not be that low.
"Hopeful near-term projects such as Dental trials and oil cooling towers were not discussed in any meaningful way."
True dental products not discussed but cooling towers were.
"BOS compounds seem to work in solution, but not when applied to a material." Yes this seems to be right so far but not with the CIBA announcement
"Taylor Collison report provided at AGM shows estimated 50% decline in total revenue FYO8. " True - but there was a stated "Greater focus on R&D"
"At the moment I don't see BOS announcements as being timely or comprehensive. Particularly the Ciba ann. just before the AGM."
Re: CIBA announcement - Maybe that's when they just got the information from CIBA?
BOS for me remains a long-term prospect. - True!
BOS Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
